Key Takeaways on AOD 9604 Investigational status: AOD 9604 is not an FDA-approved medication for fat loss or any other indication, which is why medical supervision is essential
Subcutaneous injections are also very effective, but just a bit slower entering the bloodstream than intravenous and intramuscular
Who should not use AOD-9604
For reporting the Median Time for Discharged ED Patients measure, we have previously estimated that a Medical Records Specialist would require 12.2 hours per REH annually or 464 hours (12.2 hours 38 REHs) at a cost of $25,526 (464 hours $55.06/hour) across all REHs
In addition, NNMTi promotes the secretion of antiinflammatory lipids (such as PAHSA) by adipocytes, further relieving adipose inflammation and improving metabolic function
and the conversion of 5-methyltetrahydrofolate to tetrahydrofolate